We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Exposes Kidney Cancer's Weakness

News   Feb 21, 2020 | Original story from UT Southwestern Medical Center

 
Clinical Trial Exposes Kidney Cancer's Weakness
 
 
Advertisement
 

RELATED ARTICLES

Could a CAR-T Version 2.0 Be on the Way?

News

Researchers have engineered a T cell that targets three antigens on the cancer instead of one. Using preclinical models, they then used the modified T cells to target multiple sites on acute lymphoblastic leukemia cells.

READ MORE

Purdue Scientists Work To Fast-track COVID-19 Diagnostics and Therapeutics

News

Purdue University researchers are working to move COVID-19 diagnostic and therapeutic solutions to the marketplace as soon as possible.

READ MORE

Lessons Learnt From the First Known Community-acquired COVID-19 Case in the U.S.

News

When UC Davis announced the first case of community transmission of COVID-19 in the U.S. on Feb. 26, it solved a medical mystery at the hospital and led to important changes to the U.S. Centers for Disease Control and Prevention (CDC) guidelines for novel coronavirus testing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE